Analysis of cytokines in tear fluid from atopic dermatitis patients with dupilumab-associated ocular adverse events

被引：3
|
作者：
Vuillemey, L. [1 ]
Febvay, C. [1 ]
Puzenat, E. [2 ]
Bellanger, A. P. [3 ]
Chague, C. [4 ]
Puyraveau, M. [5 ]
Delbosc, B. [1 ,4 ]
Gauthier, A. -S. [1 ,4 ]
Aubin, F. [2 ,4 ]
机构：
[1] CHU Besancon, Dept Ophthalmol, Besancon, France
[2] CHU Besancon, Dept Dermatol, Besancon, France
[3] CHU Besancon, Dept Parasitol, Besancon, France
[4] Univ Bourgogne Franche Comte, Federat Hosp Univ INCREASE, Interact Hote Greffon Tumeur Ingn Cellulaire & Ge, LabEx LipSTIC,INSERM,UMR1098,EFS BFC, Besancon, France
[5] CHU Besancon, Dept Clin Res, Besancon, France
来源：
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 2022年 / 36卷 / 03期
关键词：
VERNAL KERATOCONJUNCTIVITIS; DISEASE;
D O I：
10.1111/jdv.17729
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：E195 / E197
页数：3
相关论文
共 50 条
  • [21] High dupilumab levels in tear fluid of atopic dermatitis patients with moderate-to-severe ocular surface disease
    Achten, Roselie
    Thijs, Judith
    van der Wal, Marlot
    van Luijk, Chantal
    van Luin, Matthijs
    el Amrani, Mohsin
    Knol, Edward
    Delemarre, Eveline
    Jager, Constance den Hartog
    de Graaf, Marlies
    Bakker, Daphne
    de Boer, Joke
    van Wijk, Femke
    de Bruin-Weller, Marjolein
    CLINICAL AND TRANSLATIONAL ALLERGY, 2023, 13 (01)
  • [22] Dupilumab-Associated Ocular Surface Disease in Pediatric Atopic Dermatitis: A Single-Center Asian Experience
    Yap, Amanda Xin Yi
    Tan, Deborah
    Koh, Mark Jean-Aan
    Yang, Lin Yi
    Zhe, Koh Yi
    Wee, Lynette Wei-Yi
    PEDIATRIC DERMATOLOGY, 2024,
  • [23] Allergic contact dermatitis to Compositae: A possible cause of dupilumab-associated facial and neck dermatitis in atopic dermatitis patients?
    Napolitano, Maddalena
    Fabbrocini, Gabriella
    Patruno, Cataldo
    CONTACT DERMATITIS, 2021, 85 (04) : 473 - 474
  • [24] Dupilumab-Associated Conjunctivitis in Patients With Atopic Dermatitis: A Multicenter Real-Life Experience
    Nettis, E.
    Bonzano, L.
    Patella, V
    Detoraki, A.
    Trerotoli, P.
    Lombardo, C.
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2020, 30 (03) : 201 - +
  • [25] Dupilumab-Associated Adverse Events During Treatment of Allergic Diseases
    Kychygina, Anna
    Cassagne, Myriam
    Tauber, Marie
    Galiacy, Stephane
    Paul, Carle
    Fournie, Pierre
    Simon, Michel
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2022, 62 (03) : 519 - 533
  • [26] Ocular adverse events in patients with atopic dermatitis undergoing treatment with dupilumab: An Italian single-center experience
    Napolitano, Maddalena
    Di Guida, Adriana
    Fabbrocini, Gabriella
    Patruno, Cataldo
    DERMATOLOGIC THERAPY, 2021, 34 (05)
  • [27] Dupilumab-Associated Adverse Events During Treatment of Allergic Diseases
    Anna Kychygina
    Myriam Cassagne
    Marie Tauber
    Stéphane Galiacy
    Carle Paul
    Pierre Fournié
    Michel Simon
    Clinical Reviews in Allergy & Immunology, 2022, 62 : 519 - 533
  • [28] Dermatology-ophthalmology collaborations are needed in dupilumab-associated ocular events
    Thompson, Alyssa M.
    Yu, Le
    Hsiao, Jennifer L.
    Shi, Vivian Y.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 84 (06) : E279 - E280
  • [29] Higher prevalence of dupilumab-induced ocular adverse events in atopic dermatitis compared to asthma: A daily practice analysis
    Schlosser, Anne R.
    Bult, Lotte
    Thelen, John C.
    Thiadens, Alberta A. H. J.
    Schappin, Renske
    Nijsten, Tamar E. C.
    Veen, Johannes C. C. M. in't
    Braunstahl, Gerrit J.
    Hijnen, Dirkjan
    CLINICAL AND TRANSLATIONAL ALLERGY, 2024, 14 (08)
  • [30] Improvement of dupilumab-associated conjunctivitis after switching to upadacitinib in a patient with atopic dermatitis
    Hayama, Koremasa
    Fujita, Hideki
    DERMATOLOGIC THERAPY, 2022, 35 (07)
12345